Manning Paul B - Insider Transactions
Insider Type
individual
Companies
3
Average
6,457,579
Total Txns
12
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 2 | 0 | 2 | 2,163,002.80 | 0.00 | 2,163,002.80 |
| 2024 | 4 | 0 | 4 | 13,499,993.45 | 0.00 | 13,499,993.45 |
| 2025 | 2 | 4 | -2 | 4,125,000.00 | 18,957,475.28 | -14,832,475.28 |
| Total: | 8 | 4 | 10 | 19,787,996.25 | 18,957,475.28 | 830,520.97 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Liquidia Corporation Common Stock US53635D2027 |
27.62 USD |
188,232 Sold |
5,198,968 USD |
28/08/2025 | 29/08/2025 |
| Liquidia Corporation Common Stock US53635D2027 |
28.67 USD |
254,038 Sold |
7,283,269 USD |
28/08/2025 | 02/09/2025 |
| Liquidia Corporation Common Stock US53635D2027 |
27.94 USD |
154,337 Sold |
4,312,176 USD |
28/08/2025 | 28/08/2025 |
| Liquidia Corporation Common Stock US53635D2027 |
29.14 USD |
74,230 Sold |
2,163,062 USD |
28/08/2025 | 02/09/2025 |
| Taysha Gene Therapies, Inc. Common Stock US8776191061 |
2.75 USD |
750,000 Bought |
2,062,500 USD |
30/05/2025 | 30/05/2025 |
| Taysha Gene Therapies, Inc. Common Stock US8776191061 |
2.75 USD |
750,000 Bought |
2,062,500 USD |
30/05/2025 | 30/05/2025 |
| Candel Therapeutics, Inc. Common Stock US1374041093 |
6.00 USD |
750,000 Bought |
4,500,000 USD |
16/12/2024 | 16/12/2024 |
| Candel Therapeutics, Inc. Common Stock US1374041093 |
6.00 USD |
500,000 Bought |
3,000,000 USD |
16/12/2024 | 16/12/2024 |
| Liquidia Corporation Common Stock US53635D2027 |
8.90 USD |
337,078 Bought |
2,999,994 USD |
12/09/2024 | 12/09/2024 |
| Taysha Gene Therapies, Inc. Common Stock US8776191061 |
2.25 USD |
1,333,333 Bought |
2,999,999 USD |
27/06/2024 | 27/06/2024 |